Emergent Biosolutions (EBS) Files $180M Mixed Shelf; 3M Common for Shareholders
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Join SI Premium – FREE
Emergent Biosolutions, Inc. (NYSE: EBS) filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to $180 million of Common Stock, Preferred Stock, Debt Securities, Warrants, or any combination thereof.
Emergent also filed to sell up to 3 million of its Common on behalf of selling shareholders. Emergent will not receive proceeds from the secondary offering.
Emergent also filed to sell up to 3 million of its Common on behalf of selling shareholders. Emergent will not receive proceeds from the secondary offering.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Singularity Future Technology closes $5M registered direct offering
- Werewolf Therapeutics to merge with Ambros in $150M private placement
- ESS Tech closes $3.2M stock offering at $0.50 per share
Create E-mail Alert Related Categories
Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
